🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

European stocks slide lower ahead of E.Z. reports; Dax down 0.87%

Published 04/30/2015, 03:45 AM
© Reuters.  European stocks lose ground as markets eye E.Z. data
UK100
-
FCHI
-
DE40
-
STOXX50
-
HSBA
-
BARC
-
LLOY
-
NWG
-
HOLN
-
DBKGn
-
CBKG
-
BNPP
-
SOGN
-
SASY
-
BBVA
-
SAN
-
RIO
-
BHPB
-
ISP
-
CRDI
-
ESM24
-
1YMM24
-
NQM24
-
FRES
-
GLEN
-

Investing.com - European stocks were lower on Thursday, after mixed economic reports from Germany and Spain and as investors still awaited highly anticipated data on inflation and unemployment in the euro zone.

During European morning trade, the EURO STOXX 50 declined 0.87%, France’s CAC 40 lost 1.01%, while Germany’s DAX 30 retreated 0.65%.

Official data earlier showed that German retail sales declined by 2.3% last month, confounding expectations for a 0.4% rise. February's figure was revised to a 0.1% slip from a previously estimated 0.5% fall.

Meanwhile, separate report showed that Spain's gross domestic product rose 0.9% in the first quarter, beating expectations for a growth rate of 0.8% and up from 0.7% in the three months to December.

Investors also continued to focus on developments in Greece. On Wednesday, the country's deputy Prime Minister said Athens could seal a deal with its creditors in early May.

Mr. Dragasakis warned however that it was likely to be a "minimum agreement" to obtain the delayed funds Greece needs to avoid default.

Financial stocks were broadly lower, as French lenders Societe Generale (PARIS:SOGN) and BNP Paribas (PARIS:BNPP) plummeted 1.56% and 3%, while Germany's Commerzbank (XETRA:CBKG) and Deutsche Bank (XETRA:DBKGn) slid 0.26% and 0.70%.

Among peripheral lenders, Italy's Intesa Sanpaolo (MILAN:ISP) and Unicredit (MILAN:CRDI) lost 0.57% and 1.02% respectively, while Spanish banks BBVA (MADRID:BBVA) and Banco Santander (MADRID:SAN) tumbled 1.08% and 1.09%.

Elsewhere, Sanofi (PARIS:SASY) saw shares drop 0.61% after the French drugmaker said sales of its diabetes drug Lantus will probably decline this year after it cut the price of its top insulin product in the U.S.

On the upside, Switzerland's Holcim (SIX:HOLN) Ltd. surged 2.42% reported a rise in first-quarter profit, helped by cost cuts.

In London, FTSE 100 declined 0.43%, as U.K. lenders tracked their European counterparts lower.

Shares in Barclays (LONDON:BARC) slipped 0.26% and HSBC Holdings (LONDON:HSBA) slid 0.34%, while Lloyds Banking (LONDON:LLOY) dropped 0.55% and the Royal Bank of Scotland (LONDON:RBS) plunged 2.46%.

RBS was hit after posting a larger quarterly loss than expected as it set aside more money for restructuring and currency-manipulation probes.

Mining stocks were also on the downside, as Bhp Billiton (LONDON:BLT) edged down 0.16% and Rio Tinto (LONDON:RIO) slumped 0.36%, while Glencore Xstrata (LONDON:GLEN) and Fresnillo (LONDON:FRES) lost 0.41% and 1.08% respectively.

In the U.S., equity markets pointed to a lower open. The Dow Jones Industrial Average futures pointed to a 0.25% fall, S&P 500 futures signaled a 0.17% loss, while the Nasdaq 100 futures indicated a 0.40% decline.

Later in the day, Germany was to report on unemployment, while the euro zone was to release preliminary data on consumer prices and the unemployment rate.

The U.S. was to publish data on initial jobless claims.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.